Efficacy and safety of full oral vinorelbine (NVBO) on D1 and D8 with carboplatin (CBDCA) as first line treatment in advenced non-small lung cancer (NSCLC) patients: Results of prospective study in nonrandomized population of 259 patients

Autoři	SKŘIČKOVÁ Jana KADLEC Bohdan VENCLÍČEK Ondřej JANÁSKOVÁ Tereza KOLEK Vítězslav GRYGÁRKOVÁ Ivona ČOUPKOVÁ Helena REITERER Pavel
Rok publikování	2013
Druh	Konferenční abstrakty
Fakulta / Pracoviště MU	Lékařská fakulta
Citace
Popis	Background: The purpose was to evaluate the activity and feasibility of CBDCA together with NVBO in 1st line treatment NSCLC patients. Conclusions: The treatment with NVBO and CBDCA was well tolerated with evidence of high antitumour activity. This combination was active in all groups patients according histology.